糖尿病患者のセルフケアにおける促進要因と阻害要因に関する研究
概要
1
1.
2
1-1.
1-2.
3
2
4
1-3.
5
1-4.
7
2.
8
2-1.
9
2-2.
10
2-3.
12
3.
12
3-1.
13
3-2.
14
4.
15
4-1.
15
4-2.
18
4-3.
22
5.
23
6.
24
7.
25
1.
27
2.
28
3.
29
4.
31
5.
36
6.
38
3
1.
39
2.
40
3.
40
4.
42
5.
45
6.
48
1.
49
2.
50
3.
51
4.
53
5.
59
6.
62
1.
64
2.
65
3.
66
4.
68
5.
72
6.
74
1.
75
2.
77
3.
77
4.
80
5.
84
6.
87
1.
88
2.
89
3.
90
4.
92
5.
94
6.
95
1.
97
2.
99
3.
106
4.
109
5.
111
112
Appendix
Appendix 1
2
Appendix 2
4 5
Appendix 3
6
5
Appendix 4
7
6
Appendix 5
2
1
Appendix 6
4
3 4
Appendix 7
5
Appendix 8
6
2000
u
2000
F
7
g
g
g 95
7
g
g
7
F
g
7u
g
g
7
F
F
7
g
F
F
7
g
g
F
u
F
F
g
7
u
7
g
F
F
g
F
7
g
g
F
g
F
F
F
gg
7
F
g
F
7
g
g
g
7
g
g
F
g
g
F
Ⅱ
g
7
g
g
7
g
1.
World Health Organization (WHO),
1986 7
F 126mg/dl
F 200mg/dl
g
HbA1c
75g
g
Hemoglobin A1c
g
NGSP National Glucose Standerd Point g
F 6.5%
g
2018 7
g
F
g
F
7
g
g
7
g
g
g
F
mg g
mg
3
g
F
F
F
u
7
gβ
F
F
F
F
Fisher, Hessier, & Polonesky, 2016 Jannike,
i
Janniecke, & Vibeke, 2018 7
g
F
g
F
gg
F
F
7 g
F
g
F
F
g
7
F
7u
F
2017 7
F
Figure 1-1
2018
F 1000
,000
2017 72000
7
g
F
F
i
g
g
F
u
g
F
g
F
7
F
7
g
g
7
2500
A:
2000
B:
1500
1000
1320
1100
1000
890
950
1000
2007
2012
2016
880
680
500
690
740
1997
2002
0
F
g
χ
1-1.
g
g
g
F
7
g
u
21
u
2013 7
F
i
F
7
F
g
g
F
gg
7
g
F
F
F
g
7
7
g
g
F
7
F
g
F
7
i
F
g
F
7
F
g
F
g
F
F
7 g
g
g
F
2017
7
F
g
7
g
F
7
F
7
F
g
F
F
F
7 g
F
F
gg
F
F
1-2.
7
g
7
F
F
g
g
F
7
g
F
u
F
g
7
7
7
g 20
60
F
7
7
g
g
F
g
7
20
F
g
g
g
g
r
7
u
F
7
F
7
i
g
F
2018 7
g
g
F
F
gF
i
1
4
7
g
7
g
g
i
i
7 g
7
F 60
69
2016
i
g
gF
g
7
F
g QOL (Quality of life ;
QOL)
7
HbA1c
3
g
F1
u
10
50
26
Group 2007)7
F
1.5
F
F
g
2.2
5
g
TASC
F
Working
F
u
g
F
2013 7 g
5.9
70
F
7
F
g
F
g
7 g
g
i
g
Fuu
7
i
7
7
g
F
2016 7
7u
g QOL
7
g
g
F
7
40
g
2018 7 g
F
F
g
F
2013 7
g
F
F
2000
7
g
F
7
1-3.
g
g
F
g
g
F
i
7
g
71
g
g
7
F
g 50
7
60%
i
g
American Diabetes Association (ADA)
F
2019
500kcal
g
2018 7
g
1
g
F
i
1
―
g
7
F
g
7
F
g
g
F
2018 7
7
g
g
2016
F
, 2013 7
u
2015 7
F
F
120
3
/
g
u
,
g
g
5
g
F
g
i
i
20
60
20
g
60
150
g
2018 7
F
2017
F
F
2013
7
g
g
g
g
F
g
g
7
F
g
g
g
F
g
7
g
7
F
g
2017 7
χ
7
g
g
F
g
g
1
g
g
F
F
7
g
7
1
g
F
F
i
7u
g
i
7
F
2013 7
F
1-4.
g
7
g
F
F
F
F
χ
7
g
Levin, 1976 7
g
g
g
F
7
g
2006
7
g
g
g
g
g
g
7 g
g
g
g
g
F
g
7
7
7
g
u
g
g
g
2018 7
F
g
g
u
7
, 2015
g
750
F
50
g
30
40
F
2017 7 g
g
7
F
2004 7
F
F
2018 7
gF
g
g
g
g
u
F
g
g
g
7
7
g
30
40
g
F
7
g
g
g
g
F
g
F
7
g
F
7
g
F
Ⅱ
7
g
g
g
7
2.
g
F
g
Peel & Douglas, 2007
Lopez , 2002
F
Lieke, Marloes, & Charlotte, 2015
Michele, Reynard, & Bouknight, 2002 7
g
g
F
g
Meier, Swislocki, &
F
7
g
u
7
2-1.
u
F
7
g
g
1997 7
g
F
g
Rosenberg, 1965 7
g
1998
F
r
χ
χ
1994
g
2013 7
g
g
g
gg
2013
g
2018 7 g
g
g
F
g
2007 7
2011
2000
Dagmer, Alyssa, & Karon , 2012
Schokker, et al. 2010 7
Bandura,
F
1977
et al. 2012
Dagmer,
g
1995 7
g
g
2000
F
2002
1986 Sherer, et al. 1982 7
2011
g
7u
2000
g
7 g
F
7
7
g
Sadasivan, & Ng, 2012
Kadirvelu,
F
Sophie, et al. 2017
Sweet, et al., 2009
Williams, Fredman,
& Deci, 1998 7
2015
7
2015 Schokker, et al. 2010
g
F
7
g
g
g
2017 7 g
F
g
F
g
g
F
g
7
g
F
g
g
7
2010
g
g
g
F HbA1c
F
7
Tangney, 2004
g
g
7
2-2.
g
F
g
g
7
7
Cobb, 1976 ;
1997 7
g
F
g
F
7
g
Cohen, 1985
2000
g
χg
g
1986
2017
1998
F
g
g
2007 7
F
1999
g
2017
7
1992 7
g
F
2008
7u
g
7
g
g
2000
g
2010 7
F
2017 7
F
g
g
F
7
Kai, et al., 2016
g
2003 7Nyberg, et al. 2014
F
g
7u
g HbA1c
F
F
g
F
F
2005 7
F
2008
F
F
7u
F
F
2005 7
F
g
g
7
7
F
,
F
2002 7
g HbA1c
F
HbA1c
1996 7
F
g HbA1c
g HbA1c
F
g
2009
g
F
g
2008
2007 7
F
g
2003 7
g
7
g
g
g
g
7u
u
g
7
2-3.
2006 g
F
F
7
7
g
u
F
g
7
2017
χ
g
F
2013 7
F
g
2019 7
F
F
F
g
7
7
g
500
i
120
/
g
F 75
g
g
2017 7 g
g
g
F
F
7
g
χ
F
g
χ
2014
g
g
7
F
g
g
7
F
g
F
F
F
g
g
g
g
Ⅱ
F
Ⅱ
g
Ⅱ
g
7
u
g
g
g
7
3.
g
g
g
u
Ⅱg
r
7
g
F
F
7
g
g
7
3-1.
g
g
F
2018
F
F
, 2001 7u
g
g
F
u
F
g
2006 7
F
F
g
2004 7
F
g
F
g
g
g
g
7
g
g
QOL
F
Glass, D. C. ,1977
F
F
F
1998 7u
g
g
2015
g
g
g
1998 7
F
F
F
F
g
F
F
2013 7
7
g
F
g
χ
g
g
g
g
2017 7
F
g
F
F
g
F
7
g
g
F
F
2008
F
2016 7
g
F
g
g
7
F
F
F
g
7
Ⅱ
g
g
g
F
7
3-2.
F
7
g
g
g
g
g
F
2017 7
F
χ
2009 7
g
45
g
F
g
g
2016 7
F
Turnbull & Vallis, 1995
g
F
F
2015 7
u
g
g
g
F
u
g
7
F
2017 7
F
g
g
g
g
g
7
4.
u
g
Ⅱ
F
g
7u
g
gg
g
g
F
7
u
g
7
4-1.
g
g
F
7
F
g
7 g
F
F
7
g
7
7
g
7
4-1-1.
g
F
7u
g
g
F
g
2006 7u
F
F
2015 7
F
g
g
7
F
F
g
g
g
F
F
g
F
7
u
g
Ⅱ
g
F
g
F
F
g
g
i
g
F
7
4-1-2.
u
F
7
g
χ
g
2011
1997 7
1998
F
u
Ⅱ
7
i
F
i
7
g
g
g
7 g
g
F
7
7
g
F
7
4-1-3.
u
g
Ⅱ
2015 7
F
g
Ⅱ
7
F
g
F
g
F
g
F
7
F
7
7
u
F
4-1-4.
g
g
2010
gg
F
g
F
g
g
7
g
2014
gg
g
2008 7
F
7u
g
F
g
F
g
7
4-1-5.
u
g
Barratt, 1959
g
7
2006
2014 7
2019
F
F
, 2007
F
7
F
2014
g
g
g
7
4-1-6.
2011 7
g
g
7
g
F
i
u
F
g
F
g
u
1994
7
2009 7 g
r
F
7
F
4-1-7.
Scheier & Carver, 1985
Segerstrom, 2005 7 g
χ
g
g
2007
χ
7u
F
g
F
F
F
g
7u
g
g
7
F
u
F
g
7u
r
F
F
7
Ⅱ
g
g
7
4-2.
u
g HbA1c
F
F
7
F
7u
g
gF
g
Abraham, Brunner, & Eriksson,
2007
Lloyd, Smith, & Weinger, 2005 7
7
g
7
g
F
g
gF
7
F
7
g
F
2011 7
F
F
F
F
g 30
7
F
30
40
g
g
g
g
7
g
7
u
F
F
gg
g
g
g
7
gg
g
F
F
F
F
7u
Ⅱ
F
7
F
F
u
g
g
g
F
u
g
F
g
F
7
g
g
i
F
g
F
g
F
g
7
F
g
F
F
F
g
7
F
g
7
F
g
F
F
g
g
7
4-2-1.
2005
g
2010
30
40
HbA1c
2012
g
2013 7 g
F
F
7
g
g
2003 7
F
2012 7
g
g
F
u
u
F
7u
F
2017)7
F
F
2003
g
g
7
24
, 2004
g
, 2011 7
F
g
F
g
F
, 2019
F
g
g
7
g
u
F
Azumi, Funakoshi, & Matsumoto, 2018 7
g
F
g
g
F
7
g
g
F
7
F
g
g
g
g
2016 7 g
g
g
F
u
7
F
g
F
-
u
7 g
F
7
u
Kawakami, Araki, & Takatsuka, 1999)
g
2005 7
g
g
g
7
g
F
g
g
F
F
7
g
g
u
F
F
7 g
g
g
4-2-2.
g
F
g
g
g
u
g
7
gF
u
2011 7
g
g
u
7
2015
2016 7
g HbA1c
F
1997
F
F
2000 7
g
g
g
7
F
g
g
F
7u
F
F
F
7u
g
g
7
g
F
g
F
F
7
7 g
g
g
g
g
F
g
7
F
F
7u
7
g
F
7
u
u
g
7
g
7
F
F
g
F
g
g
7
g
F
g
7
g
g
F
g
F
g
g
g
g
F
7
4-3.
u
g
F
g
F
g
F
g
g
7
g
7
7u
F
g
gg
F
7
F
g
F
g
g
g
F
g
7u
u
F
7
7
u
g
g
g
F
F
7u
F
g
7
g
g
g 30
40
g
F
g
7
g
7
g
g
u
g
7
u
u
F
F
F
u
g
7 g
g
g
g
g
gF
F
7
7
g
F
gF
7
gg
u
F
g
7
F
g
g
F
g
7
F
F
u
g
F
g
7
g
g
HbA1c
g
g
u
F
7
g
g
u
F
7
g
g
7
g
g
F
g
F
7
F
g
g
g
g
7
5.
Ⅱ
Ⅱ
g
F
7
F
g
7
F
7
Figure 1-2
u
g
gF
7
F
g
g
g
7
g
Ⅱ
g
7
g
χ
F
F
7
g
g
g
g
F
F
7
g
g
F
g
g
7u
g
7
g
u
g
F
g
g
7 g
g
i
g
F
7
Figure 1-2
6.
Ⅱg
g
g
Ⅱ
g
Ⅱ
7
g
7
g
g
F
g
g
7
Ⅱ
g
7
Ⅱ
g
F
g
7
g
F
7
Ⅱ
7
Ⅱ
g
F
7
F
g
g
g
7
Ⅱ
g
F
g
F
7
g
g
g
u
7
g
g
g
F
g
g
7
Ⅱ
F
7
g
F
g
g
F
Ⅱ
g
g
7
Ⅱ
7
7
Ⅱ
Ⅱ
g
g
g
F
g
g
7
7.
g
7
F
g
u
F
F
F
g
7
g
g
7
7
7
Ⅱ
g
g
g
g
u
g
g
g
7
F
g
7
g
Ⅱ
g
g
1.
g
7
Ⅱ
u
g
g
7
u
F
F
g
F
F
g
g
7
g
1999
7u
g
, 2006
F
Robert, James,
Larry
2000
Toobert, Hampson, & Glasgow 2000 7
g
g
7
g
g
(
F
1997)F
g
F
g
F
g
F
g
F
2015 7
F
F
F
g
F
g
u
7
g
7
F
F
g
F
7
7 g
g
g
7
g
g
2000
F
7
F
2005 Kaplan, & Flum, (2009) Parham, Kavanagh,
& Gericke, 2009 7
F
g
7u
g
F
g
7
g
F
7
u
g
7
7
u
g
7
F
g
F
g
g
g
g
g
F
7
2.
Ⅱ
g
g
7
F
Figure 2-1
g
g
g
g
7 Ⅱ
F
g
7
g
g
F
7
g
7
Figure 2-1.
Ⅱ
g
3.
3-1.
web
70
7
g 1000
20
Ⅱ
g
75
24
g
976
901
60.46 ± 9.14
3-2.
Ⅱ
g
7
3-3.
2018
3-4.
2
20
25
g6
7
g
Ⅱg
g
F
7
g
2006 F
7
g
g
30
g
g5
g
17
7
1
9
3
3
9
7
2000 g
g
7
g
g4
u
1995
F
u
F
7
7
u
g2
g2
g
7
g
2016
7
i
u
g
g4
7
g
g
g
χ
F
F
g
7
g
χ
u
g
g4
χ
6
Ⅱ
3.
u
χ
1.
4.
u
u
g
g
2.r
u
5.r
u
7
6.
u
F
7u
6
g
g
g
g
7
3-5.
F
7
g
Cronbach g α
7
7
F
g
.350
g
g
g
F
7
2
g
7
g
7
F
7
g
(CI)
g
7
2006
g
95
, 2014 7
SPSS 25.0 for Windows
Amos 25.0
7
3-6.
Ⅱ
Ⅱ
Ⅱ
Ⅱ
g
29-64 7
g
g
F
7
4.
4-1.
g
g
HbA1c
(NSGP)
F 158
6.96 ± 0.83%
F 877
7
Table 2-1
g
49
HbA1c(NGSP)%
(SD
4-2.
50
60
70
n =976
n =118
n =337
n =349
n =172
901
75
6.96
(0.86)
87.80
15.67
56.04
78.48
47.74
25.92
99
75
7.11
(1.19)
78.81
20.33
77.11
70.33
33.89
38.13
309
28
6.95
(0.96)
88.13
18.10
81.89
73.32
44.21
30.86
328
21
6.93
(0.74)
89.39
13.75
49.85
68.19
56.44
22.92
165
7
6.87
(0.61)
90.11
11.62
18.60
88.95
48.83
13.95
g
5
F
1
7
g
1
g
.350
F
Cronbach g α
7
.561
7
g
g
gg 5
g
3
9
α
6
1
g
4
F
g
α = .878
7
4
7
1
g
4
7
F
g
α
7
= .797
4
1
g
g
7
7α
F
.745
4
g
7
g
4
F
F
g
α = .765
7
4
7
Appendix 5
4-3. ...